SRINIVAS AKKARAJU Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for SRINIVAS AKKARAJU.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of SRINIVAS AKKARAJU. SRINIVAS AKKARAJU is Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in aTYR PHARMA INC ($LIFE) and Director in ADURO BIOTECH, INC. ($ADRO) and Director in ZS Pharma, Inc. ($ZSPH) and Director in Principia Biopharma Inc. ($PRNB) and Director in Versartis, Inc. ($VSAR) and Director in Syros Pharmaceuticals, Inc. ($SYRS) and Director in Jiya Acquisition Corp. ($JYAC).

Latest Insider Trading Transactions of SRINIVAS AKKARAJU

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ARAV, LIFE, ADRO, ICPT, JYAC, PRNB, SGEN, SYRS, ZSPH

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 08 2021	ADRO	CHINOOK THERAPEUTI ...	AKKARAJU SRINIVAS	Director	Option Exercise	A	16.81	5,948	99,986	5,948
Apr 15 2021	JYAC	Jiya Acquisition C ...	AKKARAJU SRINIVAS	Director	Option Exercise	J	0.00	5,000	0	2,412,447
Mar 12 2021	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Buy	P	21.29	147,000	3,129,630	640,688	493.7 K to 640.7 K (+29.78 %)
Mar 12 2021	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Buy	P	21.55	16,559	356,846	493,688	477.1 K to 493.7 K (+3.47 %)
Mar 12 2021	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Buy	P	20.83	73,441	1,529,776	477,129	403.7 K to 477.1 K (+18.19 %)
Dec 11 2020	SYRS	Syros Pharmaceutic ...	AKKARAJU SRINIVAS	Director	Option Exercise	A	11.00	156,250	1,718,750	156,250
Dec 11 2020	SYRS	Syros Pharmaceutic ...	AKKARAJU SRINIVAS	Director	Grant	A	0.00	625,000	0	1,899,616	1.3 M to 1.9 M (+49.03 %)
Dec 11 2020	JYAC	Jiya Acquisition C ...	AKKARAJU SRINIVAS	Director	Grant	A	10.00	7,041	70,410	507,041	500 K to 507 K (+1.41 %)
Nov 25 2020	JYAC	Jiya Acquisition C ...	AKKARAJU SRINIVAS	Director	Grant	A	10.00	500,000	5,000,000	500,000	0 to 500 K
Oct 07 2020	ADRO	ADURO BIOTECH, INC ...	AKKARAJU SRINIVAS	Director	Option Exercise	A	14.77	23,522	347,420	23,522
Oct 07 2020	ADRO	ADURO BIOTECH, INC ...	AKKARAJU SRINIVAS	Director	Option Exercise	A	14.77	23,522	347,420	23,522
Oct 07 2020	ADRO	ADURO BIOTECH, INC ...	AKKARAJU SRINIVAS	Director	Grant	A	0.00	3,168,388	0	3,168,388	0 to 3.2 M
Oct 07 2020	ADRO	ADURO BIOTECH, INC ...	AKKARAJU SRINIVAS	Director	Grant	A	0.00	3,168,388	0	3,168,388	0 to 3.2 M
Aug 19 2020	SYRS	Syros Pharmaceutic ...	AKKARAJU SRINIVAS	Director	Sell	S	13.10	158,583	2,076,724	1,274,616	1.4 M to 1.3 M (-11.06 %)
Aug 19 2020	SYRS	Syros Pharmaceutic ...	AKKARAJU SRINIVAS	Director	Sell	S	13.00	744	9,672	1,433,199	1.4 M to 1.4 M (-0.05 %)
Jul 06 2020	SYRS	Syros Pharmaceutic ...	AKKARAJU SRINIVAS	Director	Sell	S	11.01	4,627	50,966	1,433,943	1.4 M to 1.4 M (-0.32 %)
Jun 25 2020	SYRS	Syros Pharmaceutic ...	AKKARAJU SRINIVAS	Director	Sell	S	11.15	54,972	612,850	1,438,570	1.5 M to 1.4 M (-3.68 %)
Jun 25 2020	SYRS	Syros Pharmaceutic ...	AKKARAJU SRINIVAS	Director	Sell	S	11.07	48,775	539,788	1,493,542	1.5 M to 1.5 M (-3.16 %)
Jun 25 2020	SYRS	Syros Pharmaceutic ...	AKKARAJU SRINIVAS	Director	Sell	S	11.11	50,953	565,930	1,542,317	1.6 M to 1.5 M (-3.20 %)
Jun 25 2020	SYRS	Syros Pharmaceutic ...	AKKARAJU SRINIVAS	Director	Sell	S	11.15	54,972	612,850	1,438,570	1.5 M to 1.4 M (-3.68 %)
Jun 25 2020	SYRS	Syros Pharmaceutic ...	AKKARAJU SRINIVAS	Director	Sell	S	11.07	48,775	539,788	1,493,542	1.5 M to 1.5 M (-3.16 %)
Jun 25 2020	SYRS	Syros Pharmaceutic ...	AKKARAJU SRINIVAS	Director	Sell	S	11.11	50,953	565,930	1,542,317	1.6 M to 1.5 M (-3.20 %)
Jun 11 2020	SYRS	Syros Pharmaceutic ...	AKKARAJU SRINIVAS	Director	Option Exercise	A	9.17	17,500	160,475	17,500
Jun 01 2020	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Option Exercise	A	72.74	2,966	215,747	2,966
Jun 01 2020	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Grant	A	0.00	1,595	0	23,121	21.5 K to 23.1 K (+7.41 %)
May 19 2020	SGEN	SEATTLE GENETICS I ...	AKKARAJU SRINIVAS	Director	Option Exercise	A	160.33	3,171	508,406	3,171
May 19 2020	SGEN	SEATTLE GENETICS I ...	AKKARAJU SRINIVAS	Director	Grant	A	0.00	1,335	0	41,503	40.2 K to 41.5 K (+3.32 %)
May 07 2020	SGEN	SEATTLE GENETICS I ...	AKKARAJU SRINIVAS	Director	Option Exercise	M	20.06	8,500	170,510	9,000
May 07 2020	SGEN	SEATTLE GENETICS I ...	AKKARAJU SRINIVAS	Director	Sell	S	167.26	8,500	1,421,710	40,168	48.7 K to 40.2 K (-17.47 %)
May 07 2020	SGEN	SEATTLE GENETICS I ...	AKKARAJU SRINIVAS	Director	Buy	M	20.06	8,500	170,510	48,668	40.2 K to 48.7 K (+21.16 %)
Dec 02 2019	ARAV	Aravive, Inc.	AKKARAJU SRINIVAS	Director	Buy	P	7.50	133,333	999,998	576,066	442.7 K to 576.1 K (+30.12 %)
Nov 22 2019	SGEN	SEATTLE GENETICS I ...	AKKARAJU SRINIVAS	Director	Option Exercise	M	19.02	4,942	93,997	0
Nov 22 2019	SGEN	SEATTLE GENETICS I ...	AKKARAJU SRINIVAS	Director	Option Exercise	M	19.02	12,558	238,853	4,942
Nov 22 2019	SGEN	SEATTLE GENETICS I ...	AKKARAJU SRINIVAS	Director	Sell	S	120.46	4,942	595,313	40,168	45.1 K to 40.2 K (-10.96 %)
Nov 22 2019	SGEN	SEATTLE GENETICS I ...	AKKARAJU SRINIVAS	Director	Buy	M	19.02	4,942	93,997	45,110	40.2 K to 45.1 K (+12.30 %)
Nov 22 2019	SGEN	SEATTLE GENETICS I ...	AKKARAJU SRINIVAS	Director	Sell	S	119.51	12,558	1,500,807	40,168	52.7 K to 40.2 K (-23.82 %)
Nov 22 2019	SGEN	SEATTLE GENETICS I ...	AKKARAJU SRINIVAS	Director	Buy	M	19.02	12,558	238,853	52,726	40.2 K to 52.7 K (+31.26 %)
Sep 13 2019	ARAV	Aravive, Inc.	AKKARAJU SRINIVAS	Director	Option Exercise	A	5.77	7,500	43,275	7,500
Aug 30 2019	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Buy	P	60.32	5,207	314,086	403,688	398.5 K to 403.7 K (+1.31 %)
Aug 22 2019	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Grant	A	64.30	1,180	75,874	398,481	397.3 K to 398.5 K (+0.30 %)
Aug 22 2019	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Grant	A	67.12	29,000	1,946,480	397,301	368.3 K to 397.3 K (+7.87 %)
Aug 22 2019	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Grant	A	65.85	37,604	2,476,223	368,301	330.7 K to 368.3 K (+11.37 %)
Jun 21 2019	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Option Exercise	A	82.25	2,174	178,812	2,174
Jun 21 2019	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Grant	A	0.00	1,570	0	21,526	20 K to 21.5 K (+7.87 %)
Jun 12 2019	SYRS	Syros Pharmaceutic ...	AKKARAJU SRINIVAS	Director	Option Exercise	A	5.60	11,000	61,600	11,000
May 22 2019	SGEN	SEATTLE GENETICS I ...	AKKARAJU SRINIVAS	Director	Option Exercise	A	64.38	7,038	453,106	7,038
May 22 2019	SGEN	SEATTLE GENETICS I ...	AKKARAJU SRINIVAS	Director	Grant	A	0.00	2,963	0	40,168	37.2 K to 40.2 K (+7.96 %)
May 22 2019	SGEN	SEATTLE GENETICS I ...	AKKARAJU SRINIVAS	Director	Option Exercise	A	64.38	7,038	453,106	7,038
May 22 2019	SGEN	SEATTLE GENETICS I ...	AKKARAJU SRINIVAS	Director	Grant	A	0.00	2,963	0	40,168	37.2 K to 40.2 K (+7.96 %)
May 14 2019	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Grant	A	83.50	119,760	9,999,960	330,697	210.9 K to 330.7 K (+56.78 %)
Apr 29 2019	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Option Exercise	M	31.90	1,001	31,932	979
Apr 29 2019	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Option Exercise	M	21.50	2,499	53,729	0
Apr 29 2019	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Buy	M	31.90	1,001	31,932	19,956	19 K to 20 K (+5.28 %)
Apr 29 2019	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Buy	M	21.50	2,499	53,729	18,955	16.5 K to 19 K (+15.19 %)
Apr 11 2019	SYRS	Syros Pharmaceutic ...	AKKARAJU SRINIVAS	Director	Option Exercise	P	8.63	133,333	1,149,997	133,333
Apr 11 2019	SYRS	Syros Pharmaceutic ...	AKKARAJU SRINIVAS	Director	Buy	P	7.50	533,332	3,999,990	1,593,270	1.1 M to 1.6 M (+50.32 %)
Feb 21 2019	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Sell	S	128.78	23,438	3,018,346	210,937	234.4 K to 210.9 K (-10.00 %)
Jan 10 2019	PRNB	Principia Biopharm ...	AKKARAJU SRINIVAS	Director	Option Exercise	A	17.00	20,475	348,075	20,475
Jan 07 2019	VSAR	Aravive, Inc.	AKKARAJU SRINIVAS	Director	Option Exercise	A	3.69	4,688	17,299	4,688
Nov 01 2018	SGEN	SEATTLE GENETICS I ...	AKKARAJU SRINIVAS	Director	Option Exercise	M	8.38	5,000	41,900	0
Nov 01 2018	SGEN	SEATTLE GENETICS I ...	AKKARAJU SRINIVAS	Director	Buy	M	8.38	5,000	41,900	37,205	32.2 K to 37.2 K (+15.53 %)
Oct 16 2018	VSAR	Aravive, Inc.	AKKARAJU SRINIVAS	Director	Grant	A	0.00	27,456	0	31,815	4.4 K to 31.8 K (+629.87 %)
Sep 20 2018	PRNB	Principia Biopharm ...	AKKARAJU SRINIVAS	Director	Option Exercise	C	0.00	208,480	0	0
Sep 20 2018	PRNB	Principia Biopharm ...	AKKARAJU SRINIVAS	Director	Buy	P	17.00	175,000	2,975,000	383,480	208.5 K to 383.5 K (+83.94 %)
Sep 20 2018	PRNB	Principia Biopharm ...	AKKARAJU SRINIVAS	Director	Buy	C	0.00	208,480	0	208,480	0 to 208.5 K
Jun 22 2018	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Option Exercise	A	85.12	2,748	233,910	2,748
Jun 22 2018	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Grant	A	0.00	1,787	0	16,456	14.7 K to 16.5 K (+12.18 %)
Jun 15 2018	VSAR	Versartis, Inc.	AKKARAJU SRINIVAS	Director	Buy	P	2.13	53,018	112,928	2,682,554	2.6 M to 2.7 M (+2.02 %)
Jun 15 2018	VSAR	Versartis, Inc.	AKKARAJU SRINIVAS	Director	Buy	P	2.13	53,018	112,928	2,682,554	2.6 M to 2.7 M (+2.02 %)
Jun 15 2018	SYRS	Syros Pharmaceutic ...	AKKARAJU SRINIVAS	Director	Option Exercise	A	12.95	11,000	142,450	11,000
Jun 08 2018	VSAR	Versartis, Inc.	AKKARAJU SRINIVAS	Director	Buy	P	2.00	231,580	463,160	2,629,536	2.4 M to 2.6 M (+9.66 %)
Jun 08 2018	VSAR	Versartis, Inc.	AKKARAJU SRINIVAS	Director	Buy	P	1.85	163,224	301,964	2,397,956	2.2 M to 2.4 M (+7.30 %)
Jun 08 2018	VSAR	Versartis, Inc.	AKKARAJU SRINIVAS	Director	Buy	P	1.74	660,681	1,149,585	2,234,732	1.6 M to 2.2 M (+41.97 %)
May 22 2018	SGEN	SEATTLE GENETICS I ...	AKKARAJU SRINIVAS	Director	Option Exercise	A	56.77	9,260	525,690	9,260
May 22 2018	SGEN	SEATTLE GENETICS I ...	AKKARAJU SRINIVAS	Director	Grant	A	0.00	3,700	0	32,205	28.5 K to 32.2 K (+12.98 %)
Apr 09 2018	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Grant	A	64.00	234,375	15,000,000	234,375	0 to 234.4 K
Feb 02 2018	SYRS	Syros Pharmaceutic ...	AKKARAJU SRINIVAS	Director	Buy	P	9.55	209,424	1,999,999	1,059,938	850.5 K to 1.1 M (+24.62 %)
Dec 22 2017	VSAR	Versartis, Inc.	AKKARAJU SRINIVAS	Director	Grant	A	0.00	11,200	0	26,155	15 K to 26.2 K (+74.89 %)
Dec 14 2017	SYRS	Syros Pharmaceutic ...	AKKARAJU SRINIVAS	Director	Buy	P	8.99	26,600	239,134	830,494	803.9 K to 830.5 K (+3.31 %)
Dec 14 2017	SYRS	Syros Pharmaceutic ...	AKKARAJU SRINIVAS	Director	Buy	P	8.97	68,400	613,548	803,894	735.5 K to 803.9 K (+9.30 %)
Dec 14 2017	SYRS	Syros Pharmaceutic ...	AKKARAJU SRINIVAS	Director	Buy	P	9.40	14,774	138,876	735,494	720.7 K to 735.5 K (+2.05 %)
Dec 05 2017	VSAR	Versartis, Inc.	AKKARAJU SRINIVAS	Director	Buy	P	2.00	42,895	85,790	1,547,896	1.5 M to 1.5 M (+2.85 %)
Dec 05 2017	VSAR	Versartis, Inc.	AKKARAJU SRINIVAS	Director	Buy	P	2.21	513,872	1,135,657	1,505,001	991.1 K to 1.5 M (+51.85 %)
Dec 05 2017	VSAR	Versartis, Inc.	AKKARAJU SRINIVAS	Director	Buy	P	2.13	419,700	893,961	991,129	571.4 K to 991.1 K (+73.45 %)
Jun 29 2017	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Option Exercise	A	122.01	2,036	248,412	2,036
Jun 29 2017	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Grant	A	0.00	1,423	0	14,669	13.2 K to 14.7 K (+10.74 %)
Jun 12 2017	SYRS	Syros Pharmaceutic ...	AKKARAJU SRINIVAS	Director	Option Exercise	A	14.26	22,000	313,720	22,000
Jun 06 2017	VSAR	Versartis, Inc.	AKKARAJU SRINIVAS	Director	Option Exercise	A	15.83	6,850	108,401	6,850
Jun 06 2017	VSAR	Versartis, Inc.	AKKARAJU SRINIVAS	Director	Grant	A	0.00	3,480	0	14,955	11.5 K to 15 K (+30.33 %)
May 23 2017	SGEN	SEATTLE GENETICS I ...	AKKARAJU SRINIVAS	Director	Option Exercise	A	66.60	9,260	616,716	9,260
May 23 2017	SGEN	SEATTLE GENETICS I ...	AKKARAJU SRINIVAS	Director	Grant	A	0.00	3,700	0	28,505	24.8 K to 28.5 K (+14.92 %)
May 11 2017	LIFE	aTYR PHARMA INC	AKKARAJU SRINIVAS	Director	Option Exercise	A	3.15	20,000	63,000	20,000
Mar 28 2017	VSAR	Versartis, Inc.	AKKARAJU SRINIVAS	Director	Buy	P	12.25	571,429	7,000,005	571,429	0 to 571.4 K
Oct 04 2016	VSAR	Versartis, Inc.	AKKARAJU SRINIVAS	Director	Buy	P	12.25	571,429	7,000,005	571,429	0 to 571.4 K
Jul 21 2016	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Option Exercise	A	145.22	1,598	232,062	1,598
Jul 21 2016	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Grant	A	0.00	1,204	0	13,246	12 K to 13.2 K (+10.00 %)
Jun 20 2016	VSAR	Versartis, Inc.	AKKARAJU SRINIVAS	Director	Option Exercise	A	10.87	28,720	312,186	28,720
Jun 20 2016	VSAR	Versartis, Inc.	AKKARAJU SRINIVAS	Director	Grant	A	0.00	6,900	0	11,475	4.6 K to 11.5 K (+150.82 %)
May 26 2016	LIFE	aTYR PHARMA INC	AKKARAJU SRINIVAS	Director	Option Exercise	A	3.33	18,000	59,940	18,000
May 24 2016	SGEN	SEATTLE GENETICS I ...	AKKARAJU SRINIVAS	Director	Option Exercise	A	38.82	9,260	359,473	9,260
May 24 2016	SGEN	SEATTLE GENETICS I ...	AKKARAJU SRINIVAS	Director	Grant	A	0.00	3,700	0	24,805	21.1 K to 24.8 K (+17.53 %)
May 17 2016	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Option Exercise	M	21.50	1,500	32,250	2,499
May 17 2016	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Buy	M	21.50	1,500	32,250	12,042	10.5 K to 12 K (+14.23 %)
Jan 29 2016	LIFE	aTYR PHARMA INC	AKKARAJU SRINIVAS	Director	Option Exercise	A	6.14	19,428	119,288	19,428
Dec 21 2015	ZSPH	ZS Pharma, Inc.	AKKARAJU SRINIVAS	Director	Option Exercise	D	55.57	4,000	222,280	0
Dec 21 2015	ZSPH	ZS Pharma, Inc.	AKKARAJU SRINIVAS	Director	Option Exercise	D	32.56	12,000	390,720	0
Dec 21 2015	ZSPH	ZS Pharma, Inc.	AKKARAJU SRINIVAS	Director	Sell	D	90.00	1,000	90,000	0	1,000 to 0 (-100.00 %)
Nov 27 2015	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Option Exercise	A	183.62	1,750	321,335	1,750
Nov 27 2015	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Grant	A	0.00	650	0	10,542	9.9 K to 10.5 K (+6.57 %)
Oct 30 2015	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Option Exercise	M	21.50	1,250	26,875	3,999
Oct 30 2015	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Buy	M	21.50	1,250	26,875	9,892	8.6 K to 9.9 K (+14.46 %)
Jul 10 2015	LIFE	aTYR PHARMA INC	AKKARAJU SRINIVAS	Director	Option Exercise	A	14.96	6,286	94,039	6,286
Jul 01 2015	VSAR	Versartis, Inc.	AKKARAJU SRINIVAS	Director	Option Exercise	A	14.73	13,100	192,963	13,100
Jul 01 2015	VSAR	Versartis, Inc.	AKKARAJU SRINIVAS	Director	Grant	A	0.00	4,575	0	4,575	0 to 4.6 K
Jun 29 2015	ZSPH	ZS Pharma, Inc.	AKKARAJU SRINIVAS	Director	Option Exercise	A	0.00	1,000	0	1,000
Jun 29 2015	ZSPH	ZS Pharma, Inc.	AKKARAJU SRINIVAS	Director	Option Exercise	A	0.00	4,000	0	4,000
May 22 2015	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Option Exercise	M	21.50	1,000	21,500	5,249
May 22 2015	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Buy	M	21.50	1,000	21,500	8,642	7.6 K to 8.6 K (+13.09 %)
May 19 2015	SGEN	SEATTLE GENETICS I ...	AKKARAJU SRINIVAS	Director	Option Exercise	A	39.94	9,260	369,844	9,260
May 19 2015	SGEN	SEATTLE GENETICS I ...	AKKARAJU SRINIVAS	Director	Grant	A	0.00	3,700	0	21,105	17.4 K to 21.1 K (+21.26 %)
May 14 2015	LIFE	aTYR PHARMA INC	AKKARAJU SRINIVAS	Director	Option Exercise	C	0.00	14,968,722	0	0
May 14 2015	LIFE	aTYR PHARMA INC	AKKARAJU SRINIVAS	Director	Buy	P	14.00	320,000	4,480,000	1,866,126	1.5 M to 1.9 M (+20.70 %)
May 14 2015	LIFE	aTYR PHARMA INC	AKKARAJU SRINIVAS	Director	Buy	C	0.00	1,546,126	0	1,546,126	0 to 1.5 M

Page: 1